Drobyski W - Search Results

1

Bhlhe40 Promotes CD4+ T Helper 1 Cell and Suppresses T Follicular Helper Cell Differentiation during Viral Infection.

Nguyen C, Kudek M, Zander R, Niu H, Shen J, Bauer A, Alson D, Khatun A, Chen Y, Sun J, Drobyski W, Edelson BT, Cui W. Nguyen C, et al. Among authors: drobyski w. J Immunol. 2024 Jun 1;212(11):1829-1842. doi: 10.4049/jimmunol.2300355. J Immunol. 2024. PMID: 38619295

2

Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection.

Xin G, Zander R, Schauder DM, Chen Y, Weinstein JS, Drobyski WR, Tarakanova V, Craft J, Cui W. Xin G, et al. Among authors: drobyski wr. Nat Commun. 2018 Nov 28;9(1):5037. doi: 10.1038/s41467-018-07492-4. Nat Commun. 2018. PMID: 30487586 Free PMC article.

3

Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.

Piper C, Zhou V, Komorowski R, Szabo A, Vincent B, Serody J, Alegre ML, Edelson BT, Taneja R, Drobyski WR. Piper C, et al. Blood. 2020 Feb 20;135(8):568-581. doi: 10.1182/blood.2019001696. Blood. 2020. PMID: 31880771 Free PMC article.

4

Self-Renewing Islet TCF1⁺ CD8 T Cells Undergo IL-27-Controlled Differentiation to Become TCF1^- Terminal Effectors during the Progression of Type 1 Diabetes.

Ciecko AE, Schauder DM, Foda B, Petrova G, Kasmani MY, Burns R, Lin CW, Drobyski WR, Cui W, Chen YG. Ciecko AE, et al. Among authors: drobyski wr. J Immunol. 2021 Oct 15;207(8):1990-2004. doi: 10.4049/jimmunol.2100362. Epub 2021 Sep 10. J Immunol. 2021. PMID: 34507949 Free PMC article.

5

Single-cell immune profiling reveals a developmentally distinct CD4+ GM-CSF+ T-cell lineage that induces GI tract GVHD.

Piper C, Hainstock E, Yin-Yuan C, Chen Y, Khatun A, Kasmani MY, Evans J, Miller JA, Gorski J, Cui W, Drobyski WR. Piper C, et al. Among authors: drobyski wr. Blood Adv. 2022 May 10;6(9):2791-2804. doi: 10.1182/bloodadvances.2021006084. Blood Adv. 2022. PMID: 35015822 Free PMC article.

6

Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.

Drobyski WR, Majewski D, Ozker K, Hanson G. Drobyski WR, et al. J Immunol. 1998 Sep 1;161(5):2610-9. J Immunol. 1998. PMID: 9725263

7

CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.

Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB, Drobyski WR. Beres AJ, et al. J Immunol. 2012 Jul 1;189(1):464-74. doi: 10.4049/jimmunol.1200886. Epub 2012 May 30. J Immunol. 2012. PMID: 22649199 Free PMC article.

8

Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

Belle L, Agle K, Zhou V, Yin-Yuan C, Komorowski R, Eastwood D, Logan B, Sun J, Ghilardi N, Cua D, Williams CB, Gaignage M, Marillier R, van Snick J, Drobyski WR. Belle L, et al. Blood. 2016 Oct 20;128(16):2068-2082. doi: 10.1182/blood-2016-02-698241. Epub 2016 Aug 3. Blood. 2016. PMID: 27488350 Free PMC article.

9

Role of the passive apoptotic pathway in graft-versus-host disease.

Drobyski WR, Komorowski R, Logan B, Gendelman M. Drobyski WR, et al. J Immunol. 2002 Aug 1;169(3):1626-33. doi: 10.4049/jimmunol.169.3.1626. J Immunol. 2002. PMID: 12133993

10

Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease.

Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR. Gendelman M, et al. J Immunol. 2004 Mar 1;172(5):3328-36. doi: 10.4049/jimmunol.172.5.3328. J Immunol. 2004. PMID: 14978141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters